News in the Life Sciences Industry | |
Results 241 - 260 out of 500 displayed. | |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » |
Medicago announces positive Phase 1 results for its COVID-19 vaccine candidate |
100 per cent of subjects who received an adjuvanted vaccine candidate developed significant antibody and cellular immune responses after two doses Read more ›› |
By: PR Newswire Association LLC. - 10 Nov 2020 |
Related companies: Medicago AB | Medicago Inc. | Medicago USA |
IRRAS AB publishes Interim Report for the period January to September 2020 |
STOCKHOLM, Nov. 10, 2020 /PRNewswire/ -- "During the third quarter IRRAS made decisive progress in a number of areas. Sales growth was seen again as commercial activity resumed after being impacted by COVID-19 restrictions, and a clinical study data was presented that demonstrated that IRRAflow... Read more ›› |
By: PR Newswire Association LLC. - 10 Nov 2020 |
Related companies: IRRAS AB |
Extended fiscal year July 2019 - December 2020 Interim report July - September 2020 |
STOCKHOLM, Nov. 10, 2020 /PRNewswire/ -- Registration preparations in Europe, Financing for MOB-015 secured and spin-off of BUPI Read more ›› |
By: PR Newswire Association LLC. - 10 Nov 2020 |
Related companies: Moberg Pharma AB (Publ) |
MEDIVIR AB - INTERIM REPORT JANUARY - SEPTEMBER 2020 |
HUDDINGE, Sweden, Nov. 10, 2020 /PRNewswire/ -- Read more ›› |
By: PR Newswire Association LLC. - 10 Nov 2020 |
Related companies: Medivir AB |
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen |
BEIJING, Nov. 10, 2020 /PRNewswire/ -- Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharmaceutica... Read more ›› |
By: PR Newswire Association LLC. - 10 Nov 2020 |
BioInvent presents new preclinical data on BI-1808, a first-in-class anti-TNFR2 antibody at the SITC 35th Anniversary Annual Meeting |
LUND, Sweden, Nov. 9, 2020 /PRNewswire/ -- BioInvent International AB ("BioInvent") (OMXS: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today presents new data on BI-1808, a monoclonal... Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020 |
Related companies: BioInvent International AB |
Alligator Bioscience presents at the SITC 35th Annual Meeting |
LUND, Sweden, Nov. 9, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it will present data from three immuno-oncology projects at the Society for Immunotherapy of Cancer's (SITC) 35th Virtual Annual Meeting, November 9-14, 2020. Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020 |
Related companies: Alligator Bioscience AB |
BioInvent and Transgene present data on next generation oncolytic virus BT-001 at the SITC 35th Anniversary Annual Meeting |
LUND, Sweden and STRASBOURG, France, Nov. 9, 2020 /PRNewswire/ -- BioInvent International AB ("BioInvent") (OMXS: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, and Transgene (Euronext Paris:... Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020 |
Related companies: BioInvent International AB |
Termination of Bridge Biotherapeutics's Collaboration and License Agreement with Boehringer Ingelheim |
SEONGNAM, South Korea, Nov. 9, 2020 /PRNewswire/ -- On November 9, 2020, Bridge Biotherapeutics (288330 KQ) reported to the Korea Stock Exchange that the Company and Boehringer Ingelheim have mutually agreed on the termination of the Collaboration and License Agreement entered into in July 2019... Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020 |
Eisai presented latest data regarding drug candidate BAN2401 at CTAD 2020 |
STOCKHOLM, Nov. 9, 2020 /PRNewswire/ -- BioArctic AB (publ) [Nasdaq Stockholm: BIOA B] announced today data on the drug candidate BAN2401 (lecanemab), which were presented by the company's partner Eisai at the Clinical Trials on Alzheimer's Disease conference (CTAD), November 4-7. The presentations... Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020 |
Related companies: BioArctic AB |
SynAct Pharma Announces Positive Interim Phase 2 Data of AP1189 in Rheumatoid Arthritis |
LUND, Sweden, Nov. 9, 2020 /PRNewswire/ -- Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020 |
Related companies: SynAct Pharma AB |
First hospital in unique digital pathology network in UK now live with Sectra's solution |
LINKÖPING, Sweden, Nov. 9, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra... Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020 |
Related companies: Sectra AB |
Calliditas Therapeutics to host conference call on positive topline results from pivotal phase 3 NefIgArd trial |
STOCKHOLM, Nov. 9, 2020 /PRNewswire/ -- On November 8, 2020, Calliditas announced positive topline results from Part A of the global Phase 3 clinical trial NefIgArd, which investigated the effect of Nefecon® versus placebo in patients with primary IgA nephropathy (IgAN). Calliditas will host... Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020 |
Related companies: Calliditas Therapeutics AB |
Dr. Alex Rovira from Hospital Vall d'Hebron joins SyntheticMR's Medical Advisory Board |
STOCKHOLM, Nov. 9, 2020 /PRNewswire/ -- Dr Rovira is Head of Neuroradiology at Vall d'Hebron Hospital in Barcelona and a Professor of Radiology and Neuroimmunology. He is specialized in diagnostic neuroradiology with particular interest in demyelinating diseases, stroke, neuro-oncology and head... Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020 |
Related companies: SyntheticMR AB |
Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China |
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 6, Merck, a leading science and technology company, announced the signing of a Letter of Intent with Donghao Lansheng... Read more ›› |
By: PR Newswire Association LLC. - 08 Nov 2020 |
Merck and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the 'Facility of the Future' a Reality |
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 7, Merck, a leading science and technology company, and Transcenta, a global biotherapeutics company, announced a strategic technology... Read more ›› |
By: PR Newswire Association LLC. - 08 Nov 2020 |
Invitation to Active Biotech’s virtual capital markets day |
Read more ›› |
By: GlobenewsWire - 06 Nov 2020 |
Related companies: Active Biotech AB |
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 and 5 November 2020 |
Read more ›› |
By: GlobenewsWire - 06 Nov 2020 |
Strong Sobi presence at American Society of Hematology 2020 Annual Meeting |
STOCKHOLM, Nov. 6, 2020 /PRNewswire/ -- Sobi(TM) will present data at the 62nd Annual Meeting of the American Society of Hematology (ASH) taking place taking place as a virtual meeting from 5-8 December. Twelve abstracts featuring five treatments have been accepted for presentation during ASH,... Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
Related companies: Swedish Orphan Biovitrum AB (Sobi™) | Sobi |
Johnson & Johnson Innovation Announces Three Strategic Collaborations with a Focus on Advancing Healthcare Solutions in China |
SHANGHAI, Nov. 6, 2020 /PRNewswire/ -- Johnson & Johnson Innovation, division of Johnson & Johnson (China) Investment Limited, announced today three new collaborations with strategic partners in China at the third China International Import Expo (CIIE) in Shanghai. These latest collaborations,... Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » |
Upcoming Life Sciences Events
- January 2021
- BioSeed Digital 2021
- NutrEvent
- AgeingFIT